{"url_path":"/sec/cpix/8-k/2026-07-01/item-1-01","section_key":"item-1-01","section_title":"Item 1.01 ****Entry into a Material Definitive Agreement.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1087294/0001104659-26-079871-index.html","accession_number":"0001104659-26-079871","cik":"0001087294","ticker":"CPIX","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1087294/0001104659-26-079871-index.html","primary_entity_key":"0001087294","primary_entity_name":"CUMBERLAND PHARMACEUTICALS INC"},"word_count":75,"has_tables":true,"body_markdown":"** **\n\n**Item 1.01****Entry into a Material Definitive Agreement.**\n\n \n\nOn July 1, 2026, Cumberland\nand Nuvo entered into Amendment No. 1 (the “**Amendment**”) to the Agreement to exclude certain contracts from the Assets\nbeing transferred to Nuvo in the Transaction.\n\n \n\nThe foregoing description\nof the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment filed\nherewith as Exhibit 2.2 and incorporated herein by reference."}